0.0308
+0.0003
+(0.82%)
At close: April 10 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -7.99 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|
| EPS Est. | -- | -1.32 | -1.27 |
| EPS Actual | -1.82 | -1.53 | -2.96 |
| Difference | -- | -0.21 | -1.69 |
| Surprise % | -- | -15.91% | -133.07% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ADXS | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Upgrade | Ladenburg Thalmann: Neutral to Buy | 5/30/2023 |
Related Tickers
SYBX Synlogic, Inc.
1.0600
+1.92%
ANTX AN2 Therapeutics, Inc.
1.2100
-6.92%
TTNP Titan Pharmaceuticals, Inc.
3.7700
+3.01%
AVTE Aerovate Therapeutics, Inc.
2.5800
+3.61%
XBIO Xenetic Biosciences, Inc.
2.3800
-1.24%
IKNA Ikena Oncology, Inc.
1.0600
-3.64%
SNNAQ Sienna Biopharmaceuticals, Inc.
0.0001
0.00%
INFIQ Infinity Pharmaceuticals, Inc.
0.0000
-95.00%
FBRX Forte Biosciences, Inc.
5.89
+3.33%
KZR Kezar Life Sciences, Inc.
3.9500
-3.66%